AMYLOID-BETA-PEPTIDE;
NUCLEATION MECHANISM;
PROTEIN AGGREGATION;
FIBRIL FORMATION;
SALT DEPENDENCE;
CALBINDIN D-9K;
LEUCINE-ZIPPER;
KINETICS;
DISEASE;
CHARGES;
D O I:
10.1039/c7sc00215g
中图分类号:
O6 [化学];
学科分类号:
0703 ;
摘要:
The aggregation of the amyloid beta peptide (A beta 42), which is linked to Alzheimer's disease, can be altered significantly by modulations of the peptide's intermolecular electrostatic interactions. Variations in sequence and solution conditions have been found to lead to highly variable aggregation behaviour. Here we modulate systematically the electrostatic interactions governing the aggregation kinetics by varying the ionic strength of the solution. We find that changes in the solution ionic strength induce a switch in the reaction pathway, altering the dominant mechanisms of aggregate multiplication. This strategy thereby allows us to continuously sample a large space of different reaction mechanisms and develop a minimal reaction network that unifies the experimental kinetics under a wide range of different conditions. More generally, this universal reaction network connects previously separate systems, such as charge mutants of the A beta 42 peptide, on a continuous mechanistic landscape, providing a unified picture of the aggregation mechanism of A beta 42.
机构:
Inst Res Biomed, Catalan Inst Res & Adv Studies, Barcelona, Spain
Inst Res Biomed, Joint Barcelona Supercomp Ctr, Inst Res Biomed, Program Computat Biol, Barcelona, SpainUniv Cambridge, Dept Chem, Cambridge CB2 1EW, England
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
Collins, SR
;
Douglass, A
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
Douglass, A
;
Vale, RD
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
Vale, RD
;
Weissman, JS
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
机构:
Inst Res Biomed, Catalan Inst Res & Adv Studies, Barcelona, Spain
Inst Res Biomed, Joint Barcelona Supercomp Ctr, Inst Res Biomed, Program Computat Biol, Barcelona, SpainUniv Cambridge, Dept Chem, Cambridge CB2 1EW, England
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
Collins, SR
;
Douglass, A
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
Douglass, A
;
Vale, RD
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA
Vale, RD
;
Weissman, JS
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USAUniv Calif San Francisco, Dept Cellular & Mol Pharmacol, Howard Hughes Med Inst, San Francisco, CA 94143 USA